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H elicobacter cinaedi is a Gram-negative spiral bacillus that generally colonizes the intestines of 
animals such as hamsters and rhesus monkeys [1].  In 
humans,  H. cinaedi infection was first reported in 1984 
in homosexual men with proctocolitis [2].  Since then,  
H. cinaedi infections have been increasingly reported,  
but the organism is still rare as a human pathogen,  and 
its clinical characteristics and relevance remain elusive.  
H. cinaedi has been isolated from immunocompromised 
patients such as those with human immunodeficiency 
virus (HIV) infection,  deficiency in humoral immunity 
[3],  and solid organ transplantation [4 , 5].  However,  
recent reviews have documented that immunocompe-
tent individuals may also be infected with H. cinaedi,  
even in a community setting [6].
Clinical manifestations of H. cinaedi infection vary 
greatly.  Bacteremia accompanying cellulitis is a typical 
form [7]; over 80% of community-acquired H. cinaedi 
bacteremia cases showed dermatologic symptoms [6].  
However,  the organism can potentially cause systemic 
infections,  resulting in arthritis [8],  infective endocar-
ditis [9],  spondylitis [10],  and meningitis [11].  Notably,  
H. cinaedi has a higher vascular affinity [7],  and it may 
induce fatal vascular infections.  To date,  H. cinaedi 
infections involving the abdominal aorta [12 , 13] and 
common iliac artery [14] have been documented.  To 
the best of our knowledge,  however,  cases involving the 
carotid artery have not yet been reported.  In the pres-
ent report,  we describe a rare case of H. cinaedi-associ-
ated carotid arteritis that was successfully treated with 
prolonged antimicrobial therapy.
Case Presentation
A 65-year-old Japanese man presented with a 1-week 
history of fever accompanied by chills,  malaise,  and 
right neck pain.  His medical history included bilateral 
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A 65-year-old Japanese man with bilateral carotid atherosclerosis presented with right neck pain and fever.  
Contrast-enhanced computed tomography suggested carotid arteritis,  and carotid ultrasonography showed an 
unstable plaque.  The patient developed a cerebral embolism,  causing a transient ischemic attack.  Helicobacter 
cinaedi was detected in blood culture,  and H. cinaedi-associated carotid arteritis was diagnosed.  Empirical anti-
biotic therapy was administered for 6 weeks.  After readmission for recurrent fever,  he was treated another 8 
weeks.  Although the relationship between H. cinaedi infection and atherosclerosis development remains unclear,  
the atherosclerotic changes in our patient’s carotid artery might have been attributable to H. cinaedi infection.
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carotid atherosclerosis (approx.  60% stenosis in the 
right carotid artery,  40% stenosis in the left) and an 
unruptured cerebral aneurysm,  for which clopidogrel 
and pitavastatin were prescribed.  He visited a dentist 
because the neck pain worsened during meals.  The 
dentist found no abnormalities,  and referred the patient 
to our hospital for a systemic evaluation.
Upon examination,  the patient’s vital signs were as 
follows: body temperature,  37.0°C; blood pressure,  
100/57 mmHg; heart rate,  65 beats per minute; oxy-
gen saturation,  98% in ambient air; and respiratory 
rate,  16 breaths per minute.  He did not complain of 
any symptoms except right mandibular cervical pain.  
Carotid bruits were detected bilaterally upon ausculta-
tion.  Skin rash was unapparent.  Laboratory blood tests 
revealed a white cell count of 7,740 /μL (neutrophils 
64%),  C-reactive protein (CRP) level of 5.9 mg/dL,  and 
erythrocyte sedimentation rate of 64 mm/h.  The results 
of a test for HIV were negative,  and immunoglobulin 
and complement levels were within normal range.
A contrast-enhanced computed tomography (CT) 
scan showed an area of increased density surrounding 
the patient’s right common carotid artery,  suggesting 
carotid arteritis.  There were no significant findings in 
his chest or abdominal cavities.  Carotid ultrasonogra-
phy revealed a 3.1 mm × 1.3 mm bouncing plaque (Fig.  
1A , B).  The patient was started on 200 mg per day of 
cilostazol,  and hospitalized for further investigation.
Two days after admission,  he developed transient 
dysarthria.  Diffusion-weighted MRI revealed a high- 
intensity area in the right corona radiate,  suggesting a 
new-onset cerebral infarction.  Repeated carotid ultra-
sonography on admission day 3 revealed that the unstable 
plaque had disappeared (Fig. 1C , D),  whereas the right 
internal carotid artery was found to be surrounded by 
thickened arterial wall and low-echoic soft tissues 
(Fig. 1D).  On day 5,  a Gram-negative spiral bacillus 
was isolated from the aerobic blood culture bottles 
(BacT/ALERT system; bioMérieux,  Marcy l’Etoile,  
France) that were inoculated at the time of the patient’s 
admission (Fig. 2).  We identified the organism as 
H. cinaedi via a polymerase chain reaction (PCR) assay 
targeted to gyrase subunit B (gyrB) by applying the 
following primers: Forward,  5’-AGG GAT TCC ACA 
AAG TGA GC-3’; Reverse,  5’-TCT TGT CCT GTG 
CGT TCA TC-3’ [15].
The results of a repeated blood culture examination 
were positive for H. cinaedi,  indicating persistent bacte-
remia.  We performed transthoracic and transesopha-
geal echocardiography,  which revealed no intracardiac 
vegetation.  The gastroscopy and colonoscopy per-
formed during the patient’s hospitalization showed no 
remarkable findings.
On the basis of the above findings,  we diagnosed the 
case as carotid arteritis caused by H. cinaedi and a subse-
quent cerebral embolism,  and we initially administered 
intravenous meropenem 2 g every 8 h.  Although surgical 
resection of the infected carotid artery was considered,  
we did not perform it since the tenderness and swelling 
ameliorated after antibiotic treatment and carotid echog-
raphy revealed an improvement of the inflammatory 
finding.  The persistent bacteremia was also confirmed to 
disappear,  and antimicrobial therapy was switched to 
intravenous ceftriaxone at a dose of 2 g every 12 h.
After 2 weeks of intravenous treatment,  laboratory 
findings were recovered to normal ranges: peripheral 
white cell count,  5,380 /μL (neutrophil 53%); CRP level,  
0.16 mg/dL; and erythrocyte sedimentation rate,  
34 mm/h.  The patient’s treatment was switched to 
100 mg oral minocycline 2× /day for 2 weeks,  and he 
was then discharged.
Three days after discharge,  however,  he revisited us 
complaining of fever and chills.  Neck pain was absent 
and carotid ultrasonography did not indicate worsening 
of the carotid arteritis.  The results of a blood culture 
examination were negative.  However,  we diagnosed the 
case as a recurrence of H. cinaedi infection and admin-
istered intravenous ceftriaxone 2 g every 12 h.  The 
patient’s clinical condition improved after 2 weeks of 
intravenous treatment.  He was then discharged with a 
prescription for 500 mg oral ampicillin 3× /day plus 
200 mg oral doxycycline 2× /day,  which was continued 
for 6 weeks.  Two months after the completion of this 
treatment,  a follow-up carotid ultrasonography demon- 
strated an improvement of the thickened arterial wall 
(Fig. 1E).  No recurrence of symptoms has been reported 
since then for > 6 months.
Discussion
We have described a rare case of H. cinaedi-associ-
ated carotid arteritis.  Persistent bacteremia suggested 
an intravascular infection,  and the clinical symptoms as 
well as imaging findings were consistent with the diag-
nosis.  This case highlights the relevance of H. cinaedi 
infection to atherosclerosis,  as has been recently pro-
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posed in the literature.
The clinical features of H. cinaedi infections have long 
been undetermined because of the low incidence and 
the difficulty in the microbiological identification of H. 
cinaedi.  According to a Japanese multicenter study,  H. 
cinaedi accounts for < 1% of positive blood cultures 
[16].  Additionally,  because of the slow growth and 
microaerophilic features of H. cinaedi,  some cases may 
remain undiagnosed [17].  A review reported that 
nearly half the cases of H. cinaedi infection required > 5 
days for positive blood culture results [18],  which is 
consistent with our patient’s case.
The atherosclerotic lesion in our patient’s carotid 
artery could be related to the onset of this rare infection.  
A report suggested the clinical relevance of H. cinaedi 
infection to the progression of atherosclerosis [19],  
which has been demonstrated in experimental athero-
sclerosis models as well [7 , 20].  It is unclear whether a 
converse relationship exists; i.e.,  whether the presence 
of atherosclerosis affects the onset of vascular H. cinaedi 
infections.  However,  previous cases of H. cinaedi 
involvement in atherosclerotic plaques support this pos-
sibility [13 , 14].  We believe that the atherosclerotic 
lesion in the carotid artery could be attributable to the 
occurrence of the rare infection in the present case.
H. cinaedi is considered highly invasive to the 
peripheral vascular system of gastrointestines,  trigger-
ing bacterial translocation to the systemic circulation 
[7].  In a study,  H. cinaedi was detected in stool samples 
from more than half of 63 patients with bacteremia,  
indicating that the blood stream infections had gastro-
intestinal origins [18].  Gastrointestinal complications 
associated with H. cinaedi bacteremia were also docu-
mented in another case series [5].  In contrast,  our 
patient did not have any previous history of abdominal 
symptoms before the onset,  and radiographic and 
endoscopic investigations did not reveal any clinically 
significant findings.  Thus,  the origin of the pathogen 
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Fig.  1　 Ultrasonographic images of the carotid arte-
ritis.  Carotid echography shows an unstable,  bouncing 
plaque (A ,B,  arrow) in the right internal carotid artery 
(ICA) of the patient,  a 65-year-old male.  The dou-
ble-headed arrow indicatesatherosclerotic plaque.  The 
intravascular plaque disappeared 3 days later (C ,D).  
The arterial wall of the ICA was circumferentially low-
echoic and thickened before treatment (D,  arrow-
heads).  The inﬂammatory change ameliorated after 
antibiotic therapy (E,  arrowheads).
was not identified.
No guidelines are currently available concerning H. 
cinaedi susceptibility testing,  or regarding the choice of 
antibiotic therapy for H. cinaedi infection.  The mini-
mum inhibitory concentrations of carbapenems,  tetra-
cycline,  and aminoglycosides for H. cinaedi are low,  but 
this organism is comparatively resistant to penicillins,  
cephalosporins,  fluoroquinolones,  and macrolides [7].  
Some reports recommend the clinical use of tetracy-
cline and aminoglycosides rather than cephalosporins,  
macrolides,  or fluoroquinolones [17].  In the present 
case,  we administered meropenem as an empirical 
treatment,  and then switched to ceftriaxone.  Both of 
these agents were administered at high doses,  consider-
ing the possibility of central nervous system infection.
Although the optimal treatment duration for H. 
cinaedi infections is unclear,  long-term therapy (2 to 
6 weeks) is preferred [8 , 21].  H. cinaedi potentially causes 
obstinate infections with a high recurrence rate [7],  which 
was also indicated in our patient’s case.  Physicians need 
to be aware of the persistence of this pathogen.
In summary,  we describe a rare case of H. cinaedi- 
associated carotid arteritis.  The patient developed a 
cerebral embolism that caused a transient ischemic attack,  
but was successfully treated with antimicrobial therapy.  
The atherosclerotic changes in his carotid artery might 
be attributable to the H. cinaedi vascular infection.
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